WO2015074667A3 - Composition for dermatitis - Google Patents

Composition for dermatitis Download PDF

Info

Publication number
WO2015074667A3
WO2015074667A3 PCT/DK2014/050399 DK2014050399W WO2015074667A3 WO 2015074667 A3 WO2015074667 A3 WO 2015074667A3 DK 2014050399 W DK2014050399 W DK 2014050399W WO 2015074667 A3 WO2015074667 A3 WO 2015074667A3
Authority
WO
WIPO (PCT)
Prior art keywords
dermatitis
composition
treatment
isd
concerns
Prior art date
Application number
PCT/DK2014/050399
Other languages
French (fr)
Other versions
WO2015074667A2 (en
Inventor
Flemming Licht
Original Assignee
Unigroup Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigroup Aps filed Critical Unigroup Aps
Priority to EP14811758.3A priority Critical patent/EP3074005A2/en
Publication of WO2015074667A2 publication Critical patent/WO2015074667A2/en
Publication of WO2015074667A3 publication Critical patent/WO2015074667A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Abstract

The invention relates to a composition for the treatment of Diaper Dermatitis (DD) and Seborrheic Dermatitis (SD), including Infantile Seborrhoeic Dermatitis (ISD). In particular, it concerns a composition comprising ethyl lactate for the treatment of DD.
PCT/DK2014/050399 2013-11-25 2014-11-24 Composition for dermatitis WO2015074667A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP14811758.3A EP3074005A2 (en) 2013-11-25 2014-11-24 Composition for dermatitis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA201370719 2013-11-25
DKPA201370719 2013-11-25
DKPA201470453 2014-07-17
DKPA201470453 2014-07-17

Publications (2)

Publication Number Publication Date
WO2015074667A2 WO2015074667A2 (en) 2015-05-28
WO2015074667A3 true WO2015074667A3 (en) 2015-07-16

Family

ID=52023131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2014/050399 WO2015074667A2 (en) 2013-11-25 2014-11-24 Composition for dermatitis

Country Status (2)

Country Link
EP (1) EP3074005A2 (en)
WO (1) WO2015074667A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3037500A1 (en) * 2015-06-19 2016-12-23 Kala Karite CHEMICAL COMPOSITION FOR DERMITE
JP6992057B2 (en) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド Non-acne-forming hair and scalp care products and how to use them

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080153757A1 (en) * 2006-12-26 2008-06-26 Ad Lunam Labs, Inc. Skin Rejuvenation Cream
US20100267662A1 (en) * 2007-11-08 2010-10-21 Ceapro, Inc. Avenanthramide-containing compositions
WO2013030459A1 (en) * 2011-09-02 2013-03-07 Clanet Oy Lipid composition for the prevention or treatment of skin problems

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080153757A1 (en) * 2006-12-26 2008-06-26 Ad Lunam Labs, Inc. Skin Rejuvenation Cream
US20100267662A1 (en) * 2007-11-08 2010-10-21 Ceapro, Inc. Avenanthramide-containing compositions
WO2013030459A1 (en) * 2011-09-02 2013-03-07 Clanet Oy Lipid composition for the prevention or treatment of skin problems

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"20 Best Oils for Treating Eczema", 21 October 2013 (2013-10-21), XP002734956, Retrieved from the Internet <URL:http://web.archive.org/web/20131021015525/http://www.herbhedgerow.co.uk/20-best-oils-for-treating-eczema/> [retrieved on 20150123] *
"Borage Oil", 24 December 2012 (2012-12-24), XP002734954, Retrieved from the Internet <URL:http://web.archive.org/web/20120824012743/http://orthomolecular.org/nutrients/borage.html> [retrieved on 20150123] *
"Kigelia Oil", 26 September 2013 (2013-09-26), XP002734955, Retrieved from the Internet <URL:http://web.archive.org/web/20130926033724/http://hempembassymeltingpot.com/kigelia-hemp-tamanu-oil> [retrieved on 20150123] *
"Sunflowers hold the key to easing itchy skin conditions", 26 June 2012 (2012-06-26), XP002734957, Retrieved from the Internet <URL:http://www.nyrnaturalnews.com/herbal-remedies/2012/06/sunflowers-hold-the-key-to-easing-itchy-skin-conditions/> [retrieved on 20150123] *
"The Benefits of Squalane (olive derived) Oil", 3 March 2012 (2012-03-03), XP002734953, Retrieved from the Internet <URL:http://web.archive.org/web/20120303174332/http://sisterra.wordpress.com/2009/04/28/the-benefits-of-squalane-olive-derived-oil/> [retrieved on 20150123] *

Also Published As

Publication number Publication date
WO2015074667A2 (en) 2015-05-28
EP3074005A2 (en) 2016-10-05

Similar Documents

Publication Publication Date Title
PH12017502298B1 (en) Antibacterial compounds
EP3068289A4 (en) Prevention and treatment of bed exits, falls, and other conditions
SI2855687T1 (en) Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
MY191574A (en) Pharmaceutical compositions comprising meloxicam
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
EP2989113A4 (en) Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
IL283432A (en) Compositions, methods and systems for the treatment of cutaneous disorders
WO2014165090A8 (en) Compounds for the treatment of tuberculosis
EP2967049A4 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
EP3060569B8 (en) Di-isopropyl-phosphinoyl-alkane (dapa) compounds as topical agents for the treatment of sensory discomfort
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
ZA201407596B (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel
EP2839833A4 (en) Topical pharmaceutical composition, method for producing the topical pharmaceutical composition, use of the topical pharmaceutical composition and method for the topical treatment of psoriasis, atopic dermatitis or chronic eczema
EP3103446A4 (en) Pharmaceutical preparation for preventing and treating progressive myopia
EP3061448A4 (en) Composition containing eugenol as active ingredient for preventing or treating atopic dermatitis
EP2991733A4 (en) Cannabidiol for the prevention and treatment of graft-versus-host disease
GB2554624B (en) Process for the Treatment of Ashes and Digestates, Treated Ashes and Digestates thus obtained and uses thereof.
HK1198632A1 (en) Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field no-
EP2910247A4 (en) Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients
WO2014194053A3 (en) Carbohydrate compounds for nutritional and therapeutic use
WO2014145126A3 (en) Methods of treating dyskinesia and related disorders
WO2015074667A3 (en) Composition for dermatitis
WO2015044434A3 (en) Fluor-9-methyl-β-carbolines

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14811758

Country of ref document: EP

Kind code of ref document: A2

REEP Request for entry into the european phase

Ref document number: 2014811758

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014811758

Country of ref document: EP